Featured Article: Salinomycin, as an autophagy modulator -- a new avenue to anticancer: a review
The anticancer effects of Salinomycin have gained much interest in recent years due to the fact that Salinomycin has been shown to suppress metastasis, provoke cell death and inhibit proliferation of cancer stem cells both in vivo and in vitro without causing any adverse side effects, potentially making it a promising chemotherapeutic drug.
In this review, J. Jiang et al. discuss and summarize the research concerning how the process of autophagy exhibits a fundamental role in the anticancer effects of Salinomycin.
Click here to access the full article.
Click here to access all of the reviews published to date in Journal of Experimental & Clinical Cancer Research.
Aims and scope
Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.
Please click here to read more.
Articles
Meeting reports now accepted
Journal of Experimental & Clinical Cancer Research now welcomes the submission of Meeting reports to help showcase novel developments presented at meetings and conferences.
Please click here for more information on the article types accepted by Journal of Experimental & Clinical Cancer Research.
Editor-in-Chief
Mauro Castelli, Regina Elena National Cancer Institute, Italy
If you would like to contact Journal of Experimental & Clinical Cancer Research, please send an email to:
Call for papers: Translational oncology
We are pleased to announce that a number of BioMed Central journals have come together to create a new cross-journal series on translational oncology.
Guest Edited by Prof Tommaso Dragani (Fondazione IRCCS Istituto Nazionale dei Tumori, Italy), the series is now accepting submissions of research articles that provide important developments in cancer research. Preclinical studies should provide a significant advance in knowledge, and have clear potential for strong clinical impact. For more information on the series, please click here to visit the series page.
Archival content
Journal of Experimental & Clinical Cancer Research has been publishing since 1982. Prior to publishing with BioMed Central from 2008, Journal of Experimental & Clinical Cancer Research was published in print. For enquiries about previous content, please contact us on:
Reviewer Acknowledgement
The editorial team of Journal of Experimental & Clinical Cancer Research would like to thank all of our reviewers who have contributed to the journal.
Click here to visit the Reviewer acknowledgements page.
Advertisement
-
-
Owned by the Association for International Promotion & Study in Tumors (APSIT)
-
Official journal of the Regina Elena National Cancer Institute, Italy
-
- Editorial Board
- Sign up for article alerts and news from this journal
Follow
2016 Journal Metrics
-
Speed
8 days from submission to first decision
11 days from acceptance to publicationCitation Impact
5.189 - 2-year Impact Factor
4.590 - 5-year Impact Factor
1.184 - Source Normalized Impact per Paper (SNIP)
1.557 - SCImago Journal Rank (SJR)Usage
519,190 Downloads
790.0 Usage FactorSocial Media Impact
124 Mentions
Advertisement
